Stockreport

AgeX Therapeutics and Lineage Cell Therapeutics Announce Issuance of U.S. Patent for Method of Generating Induced Pluripotent Stem Cells

AgeX Therapeutics, Inc.  (AGE) 
PDF ALAMEDA, Calif.--(BUSINESS WIRE)--AgeX Therapeutics, Inc. (NYSE American: AGE) and Lineage Cell Therapeutics, Inc. (NYSE American and TASE LCTX), announced today tha [Read more]